These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 8621019

  • 1. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects.
    Halberstam M, Cohen N, Shlimovich P, Rossetti L, Shamoon H.
    Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019
    [Abstract] [Full Text] [Related]

  • 2. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW, Suh KI, Joyce M, Ditzler T, Henry RR.
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [Abstract] [Full Text] [Related]

  • 3. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus.
    Cohen N, Halberstam M, Shlimovich P, Chang CJ, Shamoon H, Rossetti L.
    J Clin Invest; 1995 Jun; 95(6):2501-9. PubMed ID: 7769096
    [Abstract] [Full Text] [Related]

  • 4. Multiple defects of both hepatic and peripheral intracellular glucose processing contribute to the hyperglycaemia of NIDDM.
    Vaag A, Alford F, Henriksen FL, Christopher M, Beck-Nielsen H.
    Diabetologia; 1995 Mar; 38(3):326-36. PubMed ID: 7758880
    [Abstract] [Full Text] [Related]

  • 5. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes.
    Cusi K, Cukier S, DeFronzo RA, Torres M, Puchulu FM, Redondo JC.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1410-7. PubMed ID: 11238540
    [Abstract] [Full Text] [Related]

  • 6. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE, Levin K, Thye-Rønn P, Alford F, Hother-Nielsen O, Holst JJ, Beck-Nielsen H.
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [Abstract] [Full Text] [Related]

  • 7. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G, Misericordia P, Volpi E, Pampanelli S, Santeusanio F, Brunetti P, Bolli GB.
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [Abstract] [Full Text] [Related]

  • 8. Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus.
    Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H.
    J Clin Invest; 1995 Feb; 95(2):690-8. PubMed ID: 7860750
    [Abstract] [Full Text] [Related]

  • 9. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies.
    Goldfine AB, Patti ME, Zuberi L, Goldstein BJ, LeBlanc R, Landaker EJ, Jiang ZY, Willsky GR, Kahn CR.
    Metabolism; 2000 Mar; 49(3):400-10. PubMed ID: 10726921
    [Abstract] [Full Text] [Related]

  • 10. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
    Boden G, Chen X, Ruiz J, van Rossum GD, Turco S.
    Metabolism; 1996 Sep; 45(9):1130-5. PubMed ID: 8781301
    [Abstract] [Full Text] [Related]

  • 11. Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production.
    Perriello G, Misericordia P, Volpi E, Santucci A, Santucci C, Ferrannini E, Ventura MM, Santeusanio F, Brunetti P, Bolli GB.
    Diabetes; 1994 Jul; 43(7):920-8. PubMed ID: 8013758
    [Abstract] [Full Text] [Related]

  • 12. NIDDM in the elderly.
    Meneilly GS, Elliott T, Tessier D, Hards L, Tildesley H.
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [Abstract] [Full Text] [Related]

  • 13. Metabolic pathways of glucose in skeletal muscle of lean NIDDM patients.
    Kelley DE, Mokan M, Mandarino LJ.
    Diabetes Care; 1993 Aug; 16(8):1158-66. PubMed ID: 8375246
    [Abstract] [Full Text] [Related]

  • 14. Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
    Clore JN, Blackard WG.
    Diabetes; 1994 Feb; 43(2):256-62. PubMed ID: 8288050
    [Abstract] [Full Text] [Related]

  • 15. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J.
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM.
    Cusi K, Cunningham GR, Comstock JP.
    Diabetes Care; 1995 Jun; 18(6):843-51. PubMed ID: 7555511
    [Abstract] [Full Text] [Related]

  • 17. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus.
    Cusi K, Consoli A, DeFronzo RA.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4059-67. PubMed ID: 8923861
    [Abstract] [Full Text] [Related]

  • 18. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA.
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [Abstract] [Full Text] [Related]

  • 19. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions.
    Sumner AE, Kushner H, Sherif KD, Tulenko TN, Falkner B, Marsh JB.
    Diabetes Care; 1999 Jan; 22(1):71-7. PubMed ID: 10333906
    [Abstract] [Full Text] [Related]

  • 20. Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.
    Perseghin G, Ghosh S, Gerow K, Shulman GI.
    Diabetes; 1997 Jun; 46(6):1001-9. PubMed ID: 9166672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.